These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10526136)

  • 21. Nomifensine alters sex differences in striatal dopaminergic function.
    Poth LS; O'Connell BP; McDermott JL; Dluzen DE
    Synapse; 2012 Aug; 66(8):686-93. PubMed ID: 22389194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative effects of benztropine and nomifensine on dopamine uptake and release from striatal synaptosomes.
    McKillop D; Bradford HF
    Biochem Pharmacol; 1981 Oct; 30(20):2753-8. PubMed ID: 7317073
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of estradiol on striatal dopamine activity of female hemiparkinsonian monkeys.
    Morissette M; Di Paolo T
    J Neurosci Res; 2009 May; 87(7):1634-44. PubMed ID: 19115413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of estrogen on nigrostriatal dopamine activity: behavioral and neurochemical evidence for both pre- and postsynaptic components.
    Becker JB; Beer ME
    Behav Brain Res; 1986 Jan; 19(1):27-33. PubMed ID: 3954864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen differentially modulates nicotine-evoked dopamine release from the striatum of male and female rats.
    Dluzen DE; Anderson LI
    Neurosci Lett; 1997 Jul; 230(2):140-2. PubMed ID: 9259484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroprotective role of estrogen upon methamphetamine and related neurotoxins within the nigrostriatal dopaminergic system.
    Dluzen DE; McDermott JL
    Ann N Y Acad Sci; 2000 Sep; 914():112-26. PubMed ID: 11085314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogen as a neuroprotectant against MPTP-induced neurotoxicity in C57/B1 mice.
    Dluzen DE; McDermott JL; Liu B
    Neurotoxicol Teratol; 1996; 18(5):603-6. PubMed ID: 8888025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mazindol, nomifensine and desmethylimipramine inhibit potassium-induced release of dopamine: effect of stimulus strength.
    Dembiec-Cohen D
    J Neural Transm (Vienna); 1998; 105(6-7):735-47. PubMed ID: 9826115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals.
    Snyder GL; Keller RW; Zigmond MJ
    J Pharmacol Exp Ther; 1990 May; 253(2):867-76. PubMed ID: 2110978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen, but not testosterone, attenuates methamphetamine-evoked dopamine output from superfused striatal tissue of female and male mice.
    Myers RE; Anderson LI; Dluzen DE
    Neuropharmacology; 2003 Apr; 44(5):624-32. PubMed ID: 12668048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactive effects of tamoxifen and estrogen upon the nigrostriatal dopaminergic system.
    McDermott JL; Anderson LI; Dluzen DE
    Neuroendocrinology; 1997 Sep; 66(3):181-7. PubMed ID: 9380275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clearance and diffusion of locally applied dopamine in normal and 6-hydroxydopamine-lesioned rat striatum.
    van Horne C; Hoffer BJ; Strömberg I; Gerhardt GA
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1285-92. PubMed ID: 1469634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different effects of cocaine and nomifensine on dopamine uptake in the caudate-putamen and nucleus accumbens.
    Jones SR; Garris PA; Wightman RM
    J Pharmacol Exp Ther; 1995 Jul; 274(1):396-403. PubMed ID: 7616424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased activity and expression of tyrosine hydroxylase in the rat substantia nigra after chronic treatment with nomifensine.
    Rodríguez-Gómez JA; Romero-Ramos M; Vizuete ML; Venero JL; Cano J; Machado A
    Mol Pharmacol; 1997 Oct; 52(4):641-7. PubMed ID: 9380027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of chronic estradiol and progesterone treatments of ovariectomized rats on brain dopamine uptake sites.
    Morissette M; Di Paolo T
    J Neurochem; 1993 May; 60(5):1876-83. PubMed ID: 8473903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of phencyclidine, amphetamine and related compounds on dopamine release from and uptake into striatal synaptosomes.
    Bowyer JF; Spuhler KP; Weiner N
    J Pharmacol Exp Ther; 1984 Jun; 229(3):671-80. PubMed ID: 6726652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of estrogen agonists on amphetamine-stimulated striatal dopamine release.
    Xiao L; Becker JB
    Synapse; 1998 Aug; 29(4):379-91. PubMed ID: 9661256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of prelimbic and sensorimotor cortices on striatal neurons in the rat: electrophysiological evidence for converging inputs and the effects of 6-OHDA-induced degeneration of the substantia nigra.
    Florio T; Di Loreto S; Cerrito F; Scarnati E
    Brain Res; 1993 Aug; 619(1-2):180-8. PubMed ID: 8374776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of potassium-stimulated release of [3H]dopamine from rat striata as a result of prior exposure to cocaine, nomifensine, or mazindol.
    Dembiec D
    Neurochem Res; 1980 Mar; 5(3):345-9. PubMed ID: 7374887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time resolved dopamine overflow from synaptosomes and chopped striatal tissue with rapid superfusion.
    Kristensen EW; Bigelow JC; Wightman RM
    Brain Res; 1988 Sep; 461(1):44-52. PubMed ID: 3224276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.